The Oligonucleotide Therapeutics Society aims to foster academia and industry-based research and development of oligonucleotide therapeutics. The society envisions a new era of oligonucleotide drugs that vastly impacts therapeutic modalities, much like antibodies have revolutionized human therapeutics.
The Oligonucleotide Therapeutics Society offers Travel Grants to support outstanding doctorate graduate students and post-docs by providing a stipend to offset travel expenses to the OTS Annual Meeting. These grants promote academic and research participation by easing financial barriers to attending this key conference where experts in oligonucleotide therapeutics convene. Recipients receive stipends of $1,000 USD for travel within the same continent and $1,500 USD for international travel to the meeting.